Announcement Where Halda Therapeutics is establishing oral assets for lung and prostate cancer, the strategic deal offer from Johnson & Johnson, with its dedicated mission for its cancer sales by 2030, brings new hope for both companies for growth, business and development. Johnson & Johns...
Announcement Repare Therapeutics Inc., a clinical-level precision oncology company, has inked the definitive agreement with Xeno Therapeutics Inc. and Xeno Acquisition Corp., a non-profit biotechnology company. Under this definitive agreement, Xeno will obtain each outstanding and issued common sh...
Announcement The Indian government came ahead with the new transformation in the medical tourism landscape by announcing a transitional visa-on-arrival policy for the US and European travellers to make the reach of the best-in-class wellness retreats and health treatments more hassle-free in every...
Announcement The FDA’s new Commissioner’s National Priority Voucher program for the first 15 awardees was under tangible succession pressure. The Commissioner’s National Priority Voucher (CNPV) was introduced in June, completing the first round of awardees to now. The program is ...
Announcement The world-class leader in digital gender-affirming healthcare, GenderGP.com, has expanded its digital healthcare excellence to the United States. The motive of this expansion is to offer proven, affordable, and safe access to care for the nonbinary and transgender population globally....
Announcement In the phase of workforce cuts and exponential leadership turnover, the FDA stood grounded and constant to contributing to the advanced therapy area sincerely and in order to eliminate the hurdles hindering innovation. The cell and gene therapy landscape has experienced mixed feedback...
Announcement Hemostemix Inc. has ticked and represented its major key points from its Grand Rounds presentation held on 12th November at the University of Florida (UF, Gainesville), vascular team. The title of the session was ‘Angiogenic Cell Precursors (ACP-01): Regenerating Microcirculatio...
Announcement Telo Genomics Corp., a known face in prognostic and diagnostic innovation, is a leader ruling via its exclusive multifaceated telomere analytics, has declared that it will present an industry presentation at the Myeloma Canada MRD Testing Implementation Summit to light up on November ...
Announcement Cliniphai, a leading Framework platform and AI Agent, an intentional source to resolve the issues regarding life sciences, has entered a smart collaboration with Nested Knowledge, a key player in evidence review technology. Together, the companies will begin to leverage and streamline...
Announcement Wellgistics, a known face in the integration of technology and physical healthcare infrastructure for the major prescription drugs, have introduced EinsteinRx™. The EinsteinRx™ is a new premier prescription management solution to unify technology and physical infrastructur...
